Ticker Scorecard - ZYME Basics Company: Zymeworks Inc. IPO Date: April 28, 2017 Sector: Healthcare Industry: Biotech Market Cap: $991.15M Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 2.64% Avg Daily Range (30 D): $0.32 | 2.26% Avg Daily Range (90 D): $0.35 | 2.42% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .29M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 67 Avg Trade Size (Sh.) (90 D): 65 Institutional Trades Total Inst.Trades: 1,344 Avg Inst. Trade: $1.78M Avg Inst. Trade (30 D): $.88M Avg Inst. Trade (90 D): $1.21M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.36M Avg Closing Trade (30 D): $.91M Avg Closing Trade (90 D): $1.22M Avg Closing Volume: 107.76K     News Feb 13, 2025 @ 11:00 AM Zymeworks To Report Fourth Quarter and Full Year 2... Source: N/A Jan 17, 2025 @ 9:57 AM Engineered Multispecific Antibodies Innovation Res... Source: Researchandmarkets.Com Jan 9, 2025 @ 3:53 PM NUT Midline Carcinoma Treatment Market Research Re... Source: Researchandmarkets.Com Jan 9, 2025 @ 9:52 AM Immunotoxins Market Trends and Regional Business O... Source: Researchandmarkets.Com Nov 21, 2024 @ 11:00 AM FDA Grants U.S. Approval of Ziihera® (zanidatam... Source: Zymeworks Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.39 $-.49 $-.42 Diluted EPS $-.39 $-.49 $-.42 Revenue $ 16M $ 19.24M $ 10.03M Gross Profit $ $ $ Net Income / Loss $ -29.85M $ -37.69M $ -31.65M Operating Income / Loss $ -34.21M $ -42.89M $ -37.8M Cost of Revenue $ $ $ Net Cash Flow $ 51.39M $ -43.85M $ -42.74M PE Ratio